首页 百科知识 -对直肠癌新辅助治疗后分期的准确性

-对直肠癌新辅助治疗后分期的准确性

时间:2022-07-09 百科知识 版权反馈
【摘要】:根据文献报道,普通MRI 判断直肠癌放疗、化疗后T分期准确性较低,为43%~52%,N分期准确性60%~78%,究其原因是放疗后组织水肿、纤维化等影响了分期准确性。行术前新辅助放疗、化疗。符合化疗后改变注:直肠癌CRT治疗后,DCE-MRI仍可见异常强化的肿块,肿块曲线上升速率高于下段肠管。

根据文献报道,普通MRI(T1WI,T2WI,普通增强)判断直肠癌放疗、化疗后T分期准确性较低,为43%~52%,N分期准确性60%~78%,究其原因是放疗后组织水肿、纤维化等影响了分期准确性。而动态增强则可以有效地区分肿瘤和周围炎症组织及纤维化,因肿瘤多呈早中期明显强化,而周围炎症组织、纤维化均为晚期明显强化的特征,使得放疗、化疗后T/N再分期的准确性提高,充分显示出DCE-MRI用于放疗、化疗后术前再分期的优势。

图6-9-1 CRT治疗前后T1WI增强扫描矢状位图像

注:治疗前肠壁增厚形成肿块,动脉期肿块明显强化(A),治疗后肿块明显缩小(B)。正常肠壁延迟期强化

图6-9-2 CRT治疗前后动态增强及曲线1

注:男,54岁。便中带血3个月。入院肠镜活检:高分化腺癌,部分呈黏液腺癌。行术前新辅助放疗、化疗。治疗前MRI显示肿块于注药早期明显强化,曲线速率高于正常肠管(1.43vs0.73)(A,B);治疗后MRI肿块明显变小,原肿块部分强化曲线同下段正常肠管(0.7vs0.71)(C,D);行腹腔镜MILES手术,术后病理:标本可见大量黏液,黏液池内少量漂浮的坏死的癌细胞,符合腺癌化疗后改变

图6-9-3 CRT治疗前后动态增强及曲线2

注:女,61岁,便中带血3个月。入院肠镜:直肠腺癌,中分化。治疗前MRI:肿块于动脉期明显强化;曲线上升速率高于下段肠管(1.74vs0.60)(A,B)。治疗后MRI原肿块部位未见明显强化,曲线同下段肠管(0.95vs0.94)(C,D)。行TME手术,术后病理:直肠溃疡,肠壁黏膜及肌层未见癌细胞残留,有明显纤维化及淋巴细胞、浆细胞、嗜酸细胞浸润。符合化疗后改变

图6-9-4 治疗后未达完全缓解病例的动态增强图像及曲线

注:直肠癌CRT治疗后,DCE-MRI仍可见异常强化的肿块,肿块曲线上升速率高于下段肠管(1.06vs0.26)。行TME手术,术后病理:隆起型腺癌,中分化,侵犯全层达外周脂肪

(李春媚 陈 敏 欧阳汉 全冠民 刘佩芳)

参考文献

[1] Alonzi R, Padhani AR, Allen C. Dynamic contrast enhanced MRI in prostate cancer. Eur J Radiol, 2007, 63(3): 335-350

[2] Paldino MJ,Barboriak DP. Fundamentals of Quantitative Dynamic Contrast-Enhanced MR Imaging. Magn Reson Imaging Clin N Am, 2009, 17(2): 277-289

[3] 张盛箭,彭卫军,周良平. 动态增强MRI 基本原理及其在前列腺癌中的应用. 中国医学影像技术, 2010, 26(2): 378-380

[4] 张竞文,张清,伍建林. 动态增强磁共振成像在肿瘤的临床应用:现状及未来. 国外医学临床放射学分册, 2004, 27(3): 190-192

[5] Fuchsjager M, Shukla-Dave A, Akin O, et al. Prostate Cancer Imaging. Acta Radiol, 2008, 49(1): 107- 120

[6] McMahon CJ, Bloch BN, Lenkinski RE. Dynamic Contrast-Enhanced MR Imaging in the Evaluation of Patients with Prostate Cancer. Magn Reson Imaging Clin N Am, 2009, 17(2): 363-383

[7] Somford DM, Futterer JJ, Hambrock T. Diffusion and Perfusion MR Imaging of the Prostate. Magn Reson Imaging Clin N Am, 2008, 16(4): 685-695, ix

[8] Sinha S, Sinha U. Recent advances in breast MRI and MRS. NMR Biomed, 2009, 22(1): 3-16

[9] Moon M, Cornfeld D, Weinreb J. Dynamic Contrast-Enhanced Breast MR Imaging. Magn Reson Imaging Clin N Am, 2009, 17(2): 351-362

[10] Directions Do RK, Rusinek H, Taouli B. Dynamic Contrast-Enhanced MR Imaging of the Liver: Current Status and Future. Magn Reson Imaging Clin N Am, 2009,17(2): 339-349

[11] 孟卓, 许乙凯, 张雅萍, 等. 3.0T MR 肝脏三维容积超快速多期动态增强扫描在肝局灶性病变诊断中的价值.中国临床医学影像杂志, 2008, 19(6): 409-411

[12] Nakai A, Koyama T, Fujimoto K, et al. Functional MR Imaging of the Uterus. Magn Reson Imaging Clin N Am, 2008, 16(4): 673-684, ix

[13] Evis S, Suzanne W, Emma S, et al. MRI of malignant neoplasms of the uterine corpus and cervix. AJR, 2007, 188(6): 1577-1587

[14] Manfredi R, Gui B, Maresca G, et al. Endometrial cancer: magnetic resonance imaging. Abdom Imaging, 2005, 30(5): 626-636

[15] 马霄虹, 赵心明, 欧阳汉, 等. 3.0T MR动态增强扫描对正常胰腺及胰腺癌的定量分析. 中国医学影像技术, 2010, 26(1): 10-13

[16] 赵琼惠, 张小明, 曾南林, 等. Gd-DTPA 3D FSPGR MR动态增强在胰腺癌诊断和术前可切除性评估中的价值. 中国普外基础与临床杂志, 2005, 12(3): 301-306

[17 ] Akisik MF, Sandrasegaran K, Bu G, et al. Pancreatic Cancer: Utility of Dynamic Contrast-Enhanced MR Imaging in Assessment of Antiangiogenic Therapy. Radiology, 2010, 256(2): 441-449

[18] 王喜军, 史浩, 赵华, 等. MRI 动态增强扫描在肾细胞癌诊断中的价值. 放射学实践, 2006, 21(9): 941-944

[19] Sun MRM, Ngo L, Genega EM, et al. Renal Cell Carcinoma: Dynamic Contrast-enhanced MR Imaging for Differentiation of Tumor Subtypes—Correlation with Pathologic Findings. Radiology, 2009, 250(3): 793-802

[20] Roy FA, Geerard LB,Maarten F, et al. Rectal Cancer: MR Imaging in Local Staging-IS Gadolinium-based ContrastMaterial Helpful? Radiology, 2005, 234(1): 179-188

[21] 邱大胜,孔祥泉, 陈宪. MRI在直肠癌术前分期中的应用. 临床放射学杂志, 2008, 27(10): 1434-1436

[22] Atkin G, Taylor NJ , Daley FM, et al. Dynamic contrastenhanced magnetic resonance imaging is a poor measure of rectal cancer angiogenesis. Br J Surg, 2006, 93(8): 992-1000

[23] Dinter DJ, Horisberger K, Zechmann C, et al. Can Dynamic MR Imaging Predict Response in Patients with Rectal Cancer Undergoing Cetuximab-Based Neoadjuvant Chemoradiation? Onkologie, 2009, 32(3): 86-93

[24] de Lussanet QG, Backes WH, Griffioen AW, et al. Dynamic contrast-enhanced magnetic resonance imaging of radiation therapy-induced microcirculation changes in rectal cancer.Int J Radiat Oncol Biol Phys. 2005, 63(5):1309-1315

[25] de Vries A, Griebel J, Kremser C, et al. Monitoring of tumor microcirculation during fractionated radiation therapy in patients with rectal carcinoma : preliminary results and implications for therapy. Radiology, 2000, 217(2): 385-391

[26] Devries AF, Griebel J, Kremser C, et al. Tumor microcirculation evaluated by dynamic magnetic resonance imaging predicts therapy outcome for primary rectal carcinoma. Cancer Res , 2001, 61(6): 2513-2516

[27] 陈敏, 欧阳汉,全冠民,等. 体部磁共振诊断学. 福州:福建科学技术出版社,2010.

免责声明:以上内容源自网络,版权归原作者所有,如有侵犯您的原创版权请告知,我们将尽快删除相关内容。

我要反馈